Cuifen Hou

729 total citations
23 papers, 586 citations indexed

About

Cuifen Hou is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Cuifen Hou has authored 23 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Cuifen Hou's work include Chemokine receptors and signaling (12 papers), Chemical Synthesis and Analysis (8 papers) and Neuropeptides and Animal Physiology (5 papers). Cuifen Hou is often cited by papers focused on Chemokine receptors and signaling (12 papers), Chemical Synthesis and Analysis (8 papers) and Neuropeptides and Animal Physiology (5 papers). Cuifen Hou collaborates with scholars based in United States and Germany. Cuifen Hou's co-authors include Montserrat Camps, Peter Gierschik, Dimitrios N. Sidiropoulos, Karl H. Jakobs, Jeffry B. Stock, Monica Singer, Druie Cavender, Zhihua Sui, Dennis Argentieri and Dana L. Johnson and has published in prestigious journals such as Biochemical Journal, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Cuifen Hou

23 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuifen Hou United States 13 400 126 102 81 80 23 586
Simon Miller Japan 11 472 1.2× 80 0.6× 73 0.7× 88 1.1× 107 1.3× 16 855
Stefan Pype Belgium 13 395 1.0× 165 1.3× 63 0.6× 91 1.1× 42 0.5× 19 623
C.K. Allerston United Kingdom 14 505 1.3× 104 0.8× 108 1.1× 37 0.5× 48 0.6× 20 693
Sukalyan Chatterjee United States 16 643 1.6× 73 0.6× 126 1.2× 114 1.4× 80 1.0× 19 956
Kuniaki Sano Japan 15 493 1.2× 105 0.8× 120 1.2× 51 0.6× 62 0.8× 22 731
Chuong Nguyen United States 12 379 0.9× 72 0.6× 81 0.8× 41 0.5× 87 1.1× 17 610
Joyce T. Coll United States 8 913 2.3× 191 1.5× 200 2.0× 60 0.7× 224 2.8× 11 1.1k
Piroska Dévay Hungary 9 627 1.6× 114 0.9× 54 0.5× 84 1.0× 168 2.1× 12 729
Joan R. Kanter United States 13 547 1.4× 72 0.6× 67 0.7× 61 0.8× 33 0.4× 16 757
Jinquan Cui China 15 338 0.8× 135 1.1× 39 0.4× 24 0.3× 63 0.8× 36 531

Countries citing papers authored by Cuifen Hou

Since Specialization
Citations

This map shows the geographic impact of Cuifen Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuifen Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuifen Hou more than expected).

Fields of papers citing papers by Cuifen Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuifen Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuifen Hou. The network helps show where Cuifen Hou may publish in the future.

Co-authorship network of co-authors of Cuifen Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Cuifen Hou. A scholar is included among the top collaborators of Cuifen Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuifen Hou. Cuifen Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greco, Michael N., Mark J. Macielag, Christopher A. Teleha, et al.. (2018). 6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB1) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity. Journal of Medicinal Chemistry. 61(22). 10276–10298. 12 indexed citations
2.
Zhang, Xuqing, Zhihua Sui, Jack A. Kauffman, et al.. (2017). Evaluation of anti-diabetic effect and gall bladder function with 2-thio-5-thiomethyl substituted imidazoles as TGR5 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 27(8). 1760–1764. 14 indexed citations
3.
Zhu, Bin, Jay M. Matthews, Mingde Xia, et al.. (2016). Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 26(22). 5597–5601. 5 indexed citations
4.
Matthews, Jay M., James J. McNally, Peter J. Connolly, et al.. (2016). Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 26(21). 5346–5349. 15 indexed citations
5.
Winters, Michael P., Christopher A. Teleha, Fu‐An Kang, et al.. (2014). The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2. Bioorganic & Medicinal Chemistry Letters. 24(9). 2137–2140. 5 indexed citations
6.
Cai, Chaozhong, Cuifen Hou, John O’Neill, et al.. (2013). Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 24(4). 1239–1242. 5 indexed citations
7.
Subasinghe, Nalin L., James C. Lanter, Evan E. Opas, et al.. (2012). A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(4). 1063–1069. 17 indexed citations
8.
Cai, Chaozhong, Fu‐An Kang, Cuifen Hou, et al.. (2012). Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(1). 351–354. 6 indexed citations
9.
Zhang, Xuqing, Cuifen Hou, Monica Singer, et al.. (2012). Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate. ACS Medicinal Chemistry Letters. 3(12). 1039–1044. 14 indexed citations
10.
Zhang, Xuqing, James C. Lanter, Chaozhong Cai, et al.. (2011). Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5577–5582. 18 indexed citations
11.
Zhang, Xuqing, Cuifen Hou, Evan E. Opas, et al.. (2011). Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(20). 6042–6048. 8 indexed citations
12.
Lanter, James C., Xuqing Zhang, Nalin L. Subasinghe, et al.. (2011). The discovery of novel cyclohexylamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(24). 7496–7501. 8 indexed citations
13.
Xia, Mingde, Cuifen Hou, Duane E. DeMong, et al.. (2008). Synthesis and structure–activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(24). 6468–6470. 14 indexed citations
14.
Xia, Mingde, Cuifen Hou, Duane E. DeMong, et al.. (2008). Substituted dipiperidine alcohols as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(12). 3562–3564. 12 indexed citations
15.
Lagu, Bharat, Meng Pan, Cuifen Hou, et al.. (2007). Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 17(15). 4382–4386. 21 indexed citations
16.
Xia, Mingde, Cuifen Hou, Scott R. Pollack, et al.. (2007). Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(21). 5964–5968. 7 indexed citations
17.
Hou, Cuifen, et al.. (2004). In Vivo Activity of a Phospholipase C Inhibitor, 1-(6-((17β-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1 H-pyrrole-2,5-dione (U73122), in Acute and Chronic Inflammatory Reactions. Journal of Pharmacology and Experimental Therapeutics. 309(2). 697–704. 56 indexed citations
18.
Ahern, David G., et al.. (1999). Monitoring Inositol-Specific Phospholipase C Activity Using a Phospholipid FlashPlate®. SLAS DISCOVERY. 4(3). 151–155. 9 indexed citations
19.
Du, Ping, John Salon, Joseph A. Tamm, et al.. (1997). Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Engineering Design and Selection. 10(2). 109–117. 48 indexed citations
20.
Camps, Montserrat, Cuifen Hou, Dimitrios N. Sidiropoulos, et al.. (1992). Stimulation of phospholipase C by guanine‐nucleotide‐binding protein βγ subunits. European Journal of Biochemistry. 206(3). 821–831. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Miller Breakdown of academic impact, for papers by Stefan Pype Breakdown of academic impact, for papers by C.K. Allerston Breakdown of academic impact, for papers by Sukalyan Chatterjee Breakdown of academic impact, for papers by Kuniaki Sano Breakdown of academic impact, for papers by Chuong Nguyen Breakdown of academic impact, for papers by Joyce T. Coll Breakdown of academic impact, for papers by Piroska Dévay Breakdown of academic impact, for papers by Joan R. Kanter Breakdown of academic impact, for papers by Jinquan Cui
Rankless by CCL
2026